The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 11, 2020
Filed:
May. 30, 2018
Applicant:
Metys Pharmaceuticals Ag, Basel, CH;
Inventors:
Michael Scherz, Oberwil, CH;
Carlo Farina, Milan, IT;
Assignee:
METYS PHARMACEUTICALS AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 45/06 (2006.01); A61K 31/4188 (2006.01); A61K 31/7068 (2006.01); A61K 31/7072 (2006.01); A61K 31/708 (2006.01); A61P 25/02 (2006.01); A61P 19/02 (2006.01); A61P 25/24 (2006.01); A61K 31/282 (2006.01); A61K 31/407 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/282 (2013.01); A61K 31/407 (2013.01); A61K 31/4188 (2013.01); A61K 31/708 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 45/06 (2013.01); A61P 19/02 (2018.01); A61P 25/02 (2018.01); A61P 25/24 (2018.01); C07B 2200/07 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present invention relates to a composition of enantiomers of 3,6,7,7a-tetrahydro-1H-pyrrolo[1,5-a]imidazole-2,5-dione and pharmaceutically acceptable solvates or co-crystals thereof in a certain ratio, a pharmaceutical composition comprising said composition, its use as a medicament and the use of the inventive compositions or pharmaceutical compositions in the treatment and/or prevention of a disease or disorder typically and preferably selected from peripheral sensory neuropathy, preferably peripheral neuropathic pain; seizure; depression; or cognitive impairment.